These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6362962)
1. [Clinical evaluation of a new choleretic administered in normal and high doses to patients with chronic hepatocholecytopathies]. Petracca EG; Cavazzuti C Clin Ter; 1983 Oct; 107(2):109-19. PubMed ID: 6362962 [No Abstract] [Full Text] [Related]
2. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes]. Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665 [No Abstract] [Full Text] [Related]
3. [Epomediol-induced modifications of the biohumoral picture in hepatic cirrhosis with or without cholestasis]. Alberti A; Andreuzzi B; Santese R; Rotondo F Clin Ter; 1983 Feb; 104(3):227-33. PubMed ID: 6345051 [No Abstract] [Full Text] [Related]
4. [Clinical study of an original synthetic choleretic: 3,4-methylenedioxycinnamic acid]. Tacca GP Minerva Gastroenterol; 1974; 20(4):168-74. PubMed ID: 4459733 [No Abstract] [Full Text] [Related]
5. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis. Agca E; Akcay A; Simsek H Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001 [No Abstract] [Full Text] [Related]
6. [Experience in treatment of chronic toxic hepatitis by ursodeoxicholic acid]. Agzamova GS Med Tr Prom Ekol; 2001; (1):39-42. PubMed ID: 11221110 [No Abstract] [Full Text] [Related]
7. [Xylitol as a choleretic and cholecystokinetic agent]. Gruncharov V Vutr Boles; 1973; 12(2):69-73. PubMed ID: 4713058 [No Abstract] [Full Text] [Related]
8. [Study of an hepatic analeptic by enzyme determinations and hepatic clearance tests]. Boisson J Ann Gastroenterol Hepatol (Paris); 1972; 8(2):191-6. PubMed ID: 5056542 [No Abstract] [Full Text] [Related]
9. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study]. Cremoncini C; Tominz L Minerva Med; 1968 Oct; 59(82):4359-68. PubMed ID: 5683717 [No Abstract] [Full Text] [Related]
10. [Effect of hepatophyt on the choleretic function of the liver damaged by tetracycline]. Nikolaev SM; Sambueva ZG; Chekhirova GV; Tsyrenzhalov AV Antibiot Khimioter; 2003; 48(4):24-6. PubMed ID: 13677134 [TBL] [Abstract][Full Text] [Related]
11. [Controlled clinical evaluation of cicloxilic acid in hepatopathies caused by psychopharmacological agents]. Bocci U; Beretta G Clin Ter; 1980 May; 93(4):373-88. PubMed ID: 6998639 [No Abstract] [Full Text] [Related]
12. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases]. Marchettini G; Maggi P; Benvenuti C Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683 [No Abstract] [Full Text] [Related]
14. [Effect of pecvocrine on the biligenic function of the liver in acute experimental hepatitis]. Pasechnik IKh Farmakol Toksikol; 1973; 36(1):103-4. PubMed ID: 4685141 [No Abstract] [Full Text] [Related]